Gene Expression Profile Class Change in a Case of Aggressive, Recurrent Melanoma
- 1 December 2023
- journal article
- research article
- Published by SAGE Publications in Journal of Vitreoretinal Diseases
- Vol. 8 (1) , 93-96
Abstract
Purpose: To report a novel case of a recurrent melanoma that had a change in its genetic expression profile (GEP) class over a 2-year period. Methods: This retrospective case study evaluated a patient with a recurrent uveal melanoma that changed classes from 1A to 1B. Results: A large melanoma was first treated with brachytherapy, and during that time genetic testing revealed a class 1A tumor. Two years later the tumor was noted to be enlarging, and the patient elected for enucleation. Subsequent GEP showed a class 1B tumor. Conclusions: An aggressive and large recurrent uveal melanoma that had changed from a class 1A to a class 1B tumor on subsequent GEP testing has never been reported before to our knowledge. It may imply that a recurrent or aggressive tumor has more mutations over time that could lead to a higher risk for metastasis. The natural course of a tumor’s GEP class should be explored further.Keywords
This publication has 18 references indexed in Scilit:
- PRAME as an Independent Biomarker for Metastasis in Uveal MelanomaClinical Cancer Research, 2016
- Frequency and Implications of Discordant Gene Expression Profile Class in Posterior Uveal Melanomas Sampled by Fine Needle Aspiration BiopsyAmerican Journal of Ophthalmology, 2015
- Uveal Melanoma Gene Expression Status Post RadiotherapyOptometry and Vision Science, 2015
- Uveal melanoma: Estimating prognosisIndian Journal Of Ophthalmology, 2015
- Spectral-Domain Optical Coherence Tomography Evaluation of Choroidal Melanoma and Nevus Fine-Needle Aspiration Biopsy Incision SitesOphthalmic Surgery, Lasers and Imaging Retina, 2014
- Collaborative Ocular Oncology Group Report Number 1: Prospective Validation of a Multi-Gene Prognostic Assay in Uveal MelanomaOphthalmology, 2012
- An Accurate, Clinically Feasible Multi-Gene Expression Assay for Predicting Metastasis in Uveal MelanomaThe Journal of Molecular Diagnostics, 2010
- Iodine brachytherapy as an alternative to enucleation for large uveal melanomasOphthalmology, 2003
- Late radiation failures after iodine 125 brachytherapy for uveal melanoma compared with charged-particle (proton or helium ion) therapyOphthalmology, 2002
- The COMS Randomized Trial of Iodine 125 Brachytherapy for Choroidal Melanoma, III: Initial Mortality FindingsArchives of Ophthalmology (1950), 2001